Skip to content
Pharma Observatory a Scientist.com platform

Clinical trial

Prospective Blinded Evaluation of Salivary Transcriptome Biomarkers for Non-small Cell Lung Cancer Detection

NCT02294578 is registered in ClinicalTrials.gov with PeriRx as lead sponsor.

NCT NCT02294578
Email me this page as a PDF

Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.

Get the NCT02294578 report as a PDF

The PDF carries up to 50 rows of each section, where the page shows the first few, with the sources listed. Enter a work email and confirm it from the message we send, and the report follows by email.

Registry record

As filed in ClinicalTrials.gov.

Title
Prospective Blinded Evaluation of Salivary Transcriptome Biomarkers for Non-small Cell Lung Cancer Detection
Lead sponsor
PeriRx
Phase
Observational
Overall status
Unknown status
Start date
December 31, 2014
Completion date
March 31, 2019
Enrollment
166 (estimated)
Sites
2

Conditions

As the registry lists them; a condition with its own page is linked.

lung cancer